The majority of patients with follicular lymphoma and a subset of patients with diffuse large B-cell lymphoma (DLBCL) have a translocation between chromosomes 14 and 18 which results in the fusion of the immunoglobulin heavy chain gene (IGH), located at chromosome region 14q32, with the BCL2 gene, located at chromosome region 18q21.
Product Main Components
The kit consists of BCL2/IGH dual color probe
Component name
Specifications
Quantity
Main components
BCL2/IGH dual color probe
100μL/Tube
1
BCL2 Orange probe, IGH Green probe
Intended use
The reagent carries out in situ hybridization staining on the basis of routine staining to provide doctors with auxiliary information for diagnosis. The test results are only for clinical reference and should not be used as the only basis for clinical diagnosis. Clinicians should comprehensively judge the test results in combination with the patient's condition, drug indications, treatment response and other laboratory test indicators.
Detection principle
Fluorescence in situ hybridization is a technique for directly observing specific nucleic acids in cells in vitro. According to the principle of base complementary pairing, the specific probe is complementary to the target sequence in the cell. Due to the fluorescence of the probe, the gene state of the hybrid probe and the target sequence can be clearly observed under the fluorescence microscope under the appropriate excitation light.
Applicable Instruments
Fluorescence microscopy imaging systems, including fluorescence microscopy and filter sets suitable for DAPI (367/452), Green (495/517), and Orange (547/565).